Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.

Yang CC, Lin HP, Chen CS, Yang YT, Tseng PH, Rangnekar VM, Chen CS.

J Biol Chem. 2003 Jul 11;278(28):25872-8. Epub 2003 May 8.

2.

Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system.

Chong ZZ, Maiese K.

Histol Histopathol. 2004 Apr;19(2):495-504. doi: 10.14670/HH-19.495. Review.

3.

Antisense approaches in prostate cancer.

Chi KN, Gleave ME.

Expert Opin Biol Ther. 2004 Jun;4(6):927-36. Review.

PMID:
15174974
4.

Targeting apoptosis in prostate cancer.

DiPaola RS, Patel J, Rafi MM.

Hematol Oncol Clin North Am. 2001 Jun;15(3):509-24. Review.

PMID:
11525294
5.

Apoptosis in cancer: cause and cure.

Kaufmann SH, Gores GJ.

Bioessays. 2000 Nov;22(11):1007-17. Review.

PMID:
11056477
6.

Chemosensitization of prostate cancer by modulating Bcl-2 family proteins.

Karnak D, Xu L.

Curr Drug Targets. 2010 Jun;11(6):699-707. Review.

7.

Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy.

O'Neill J, Manion M, Schwartz P, Hockenbery DM.

Biochim Biophys Acta. 2004 Dec 10;1705(1):43-51. Review.

PMID:
15585172
8.

On the InterAktion between hexokinase and the mitochondrion.

Birnbaum MJ.

Dev Cell. 2004 Dec;7(6):781-2. Review.

9.

Bcl-2 proteins: master switches at the intersection of death signaling and the survival control by Raf kinases.

Rapp UR, Rennefahrt U, Troppmair J.

Biochim Biophys Acta. 2004 Mar 1;1644(2-3):149-58. Review.

10.

Cytokine-mediated cell survival.

Inaba T.

Int J Hematol. 2004 Oct;80(3):210-4. Review.

PMID:
15540894
11.

BCL2: A promising cancer therapeutic target.

Radha G, Raghavan SC.

Biochim Biophys Acta. 2017 Aug;1868(1):309-314. doi: 10.1016/j.bbcan.2017.06.004. Epub 2017 Jun 21. Review.

PMID:
28647470
12.

The role of Reg IV in colorectal cancer, as a potential therapeutic target.

Hu Y, Pan C, Hu J, Zhang S.

Contemp Oncol (Pozn). 2015;19(4):261-4. doi: 10.5114/wo.2015.54385. Epub 2015 Jul 8. Review.

13.

The regulation and biosynthesis of antimycins.

Seipke RF, Hutchings MI.

Beilstein J Org Chem. 2013 Nov 19;9:2556-63. doi: 10.3762/bjoc.9.290. Review.

Supplemental Content

Support Center